WHO ICTRP trial
Comparison of general anesthesia with new intravenous anesthetic remimazolam…
JPRN-UMIN000041953 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000041953 |
|---|---|
| Public title | Comparison of general anesthesia with new intravenous anesthetic remimazolam besilate versus propofol |
| Scientific title | Comparison of general anesthesia with new intravenous anesthetic remimazolam besilate versus propofol - Comparison of general anesthesia with new intravenous anesthetic remimazolam besilate versus propofol |
| Primary sponsor | Tsurumi University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | jaw deformity, jaw cyst, impacted tooth |
| Interventions | Remimazolam beslate is administered intravenously under general anesthesia.The basic dose is 12 mg/kg/h for introducing anesthesia and 1 mg/kg/h for maintaining anesthesia, and the dose is appropriately reduced according to age and… |
| Registration date | Jan 10, 2021 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: